pci-32765 and Leukemia--Myelogenous--Chronic--BCR-ABL-Positive

pci-32765 has been researched along with Leukemia--Myelogenous--Chronic--BCR-ABL-Positive* in 2 studies

Other Studies

2 other study(ies) available for pci-32765 and Leukemia--Myelogenous--Chronic--BCR-ABL-Positive

ArticleYear
Ibrutinib-associated rash: a single-centre experience of clinicopathological features and management.
    British journal of haematology, 2018, Volume: 180, Issue:1

    Topics: Adenine; Antineoplastic Agents; Biopsy; Disease Management; Exanthema; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Piperidines; Protein Kinase Inhibitors; Pyrazoles; Pyrimidines; Severity of Illness Index; Symptom Assessment

2018
58th American Society of Hematology Annual Meeting.
    The Lancet. Haematology, 2017, Volume: 4, Issue:1

    Topics: ADAMTS13 Protein; Adenine; Antibodies, Monoclonal; Antineoplastic Agents; Central Venous Catheters; fms-Like Tyrosine Kinase 3; Genetic Therapy; Graft vs Host Disease; Hematologic Diseases; Hemophilia B; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Multiple Myeloma; Mutation; Piperidines; Protein Kinase Inhibitors; Purpura, Thrombotic Thrombocytopenic; Pyrazoles; Pyrimidines; Recombinant Proteins; Societies, Medical; Thrombosis

2017